Eos Biotechnology

Human antibody therapeutics to attack these genome-derived targets for cancer.

placeSan Francisco, California, United States calendar_todayFounded 1997 language eosbiotech.com

Innovation

2 patent families — focus: Chemistry & metallurgy, Physics & computing; filing pace dormant. Cited 4 times.

YearFilings
20131

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon